Cystic Fibrosis



Cystic Fibrosis


Gerald F. Abbott, MD










Axial NECT shows cylindrical bronchiectasis image, centrilobular nodules, and tree-in-bud opacities that predominantly involve both upper lobes.






Axial NECT shows a small subpleural consolidation image, mild cylindrical bronchiectasis image, and small centrilobular nodules image in this patient with cystic fibrosis.


TERMINOLOGY


Abbreviations and Synonyms



  • Cystic fibrosis (CF), mucoviscidosis


Definitions



  • Hereditary disorder that affects gene regulating chloride transport



    • Production of abnormal secretions from exocrine glands (salivary and sweat glands, pancreas, large bowel, tracheobronchial tree)


    • Thick viscous secretions affecting multiple organs, primarily lungs and pancreas


  • Accounts for up to 25% of adult cases of bronchiectasis


IMAGING FINDINGS


General Features



  • Best diagnostic clue: Diffuse bronchiectasis with predominant involvement of upper lobes


  • Patient position/location



    • Predominant abnormalities in upper lobes



      • Right upper lobe often 1st and most severely affected


CT Findings



  • Airways



    • Primary site of pathology in CF


    • Bronchial wall thickening earliest finding



      • Due to inflammation or infection of airway wall; precedes development of bronchiectasis


    • Bronchiectasis most common finding; diffuse involvement, usually predominant in both upper lobes


    • Mucous plugging manifests as centrilobular nodular, tubular, and V- or Y-shaped (tree-in-bud) opacities


  • Lung



    • Air-trapping



      • Hyperinflation is early finding; may be reversible initially, then permanent (100%)


      • Mosaic lung attenuation


    • Recurrent areas of consolidation



      • May represent superimposed pneumonia or atelectasis and retained secretions distal to bronchial obstruction



    • Cystic or bullous changes may occur, typically subpleural in upper lobes (predisposes to pneumothorax) in end-stage disease


  • Cardiac



    • Acute increase in heart size (cor pulmonale; ominous clinical sign)


    • Pulmonary arterial hypertension in end-stage disease


  • Associated findings



    • Mild lymphadenopathy (reactive) common


    • Pleural effusions uncommon


  • Evolution



    • Early



      • Mild bronchial wall thickening


      • Regional (lobular) air-trapping


      • Centrilobular nodules (from mucus plugging in peripheral airways)


    • Moderate progression



      • Increased bronchial wall thickening


      • Development of cylindrical bronchiectasis


      • Increased air-trapping (segmental to lobar)


    • End-stage



      • Progression to varicose or saccular bronchiectasis


      • More proximal mucus plugging


      • Chronic lobar collapse


  • Correlation with pulmonary function



    • Dissociation between progressive structural damage evidenced by CT and stable or improved pulmonary function tests in many patients



      • CT more sensitive to deterioration in clinical status than pulmonary function tests


    • Scoring systems: Bhalla and others



      • Shown to have good interobserver agreement


      • No consensus yet as to which is most appropriate for evaluating new therapies or monitoring disease


Radiographic Findings



  • Radiography



    • Less sensitive for earliest changes in CF


    • Primary role is longitudinal assessment


Angiographic Findings



  • Bronchial artery embolization for hemoptysis


Imaging Recommendations



  • Best imaging tool



    • Chest radiography every 2-4 years recommended by Cystic Fibrosis Foundation



      • Annually for those with frequent infections or declining lung function


    • CT role currently being defined



      • Now being used as outcome measure for therapeutic trials


  • Protocol advice



    • Role of CT tempered by large life-time radiation dose



      • 1st CT often in childhood


      • Chest CT average dose of 6 mSv


    • Radiation dose reduction important



      • Incremental CT vs. volumetric scans (reduces dose 8x)


      • Lower mAs to 20 (reduces dose 10x from typical mAs of 200)


DIFFERENTIAL DIAGNOSIS


Allergic Bronchopulmonary Aspergillosis



  • Central upper lobe predominant bronchiectasis


  • History of asthma, often eosinophilia


  • 10% of patients with CF have allergic bronchopulmonary aspergillosis (ABPA)


Immotile Cilia Syndrome



  • Not upper lobe predominant


  • Dextrocardia or situs inversus; sinusitis also common


Postinfectious Bronchiectasis



  • Usually unilateral, lobar, or sublobar; often lower lobe (except for tuberculosis)


Williams-Campbell Syndrome



  • Rare; congenital deficiency of cartilage in subsegmental bronchi


  • Bronchiectasis limited to 4th-6th generation bronchi



Tuberculosis



  • Reactivation can produce upper lobe volume loss; bronchiectasis in 50%


  • Often associated with calcifications in pulmonary granulomas and hilar mediastinal lymph nodes

Sep 20, 2016 | Posted by in RESPIRATORY IMAGING | Comments Off on Cystic Fibrosis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access